LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 14641

Search options

  1. Book ; Online: Tests of $CP$ symmetry in the entangled $\Xi^0-\bar{\Xi}^0$ Pairs

    BESIII Collaboration / Ablikim, M. / Achasov, M. N. / Adlarson, P. / Ai, X. C. / Aliberti, R. / Amoroso, A. / An, M. R. / An, Q. / Bai, Y. / Bakina, O. / Balossino, I. / Ban, Y. / Batozskaya, V. / Begzsuren, K. / Berger, N. / Berlowski, M. / Bertani, M. / Bettoni, D. /
    Bianchi, F. / Bianco, E. / Bortone, A. / Boyko, I. / Briere, R. A. / Brueggemann, A. / Cai, H. / Cai, X. / Calcaterra, A. / Cao, G. F. / Cao, N. / Cetin, S. A. / Chang, J. F. / Chang, T. T. / Chang, W. L. / Che, G. R. / Chelkov, G. / Chen, C. / Chen, Chao / Chen, G. / Chen, H. S. / Chen, M. L. / Chen, S. J. / Chen, S. M. / Chen, T. / Chen, X. R. / Chen, X. T. / Chen, Y. B. / Chen, Y. Q. / Chen, Z. J. / Cheng, W. S. / Choi, S. K. / Chu, X. / Cibinetto, G. / Coen, S. C. / Cossio, F. / Cui, J. J. / Dai, H. L. / Dai, J. P. / Dbeyssi, A. / de Boer, R. E. / Dedovich, D. / Deng, Z. Y. / Denig, A. / Denysenko, I. / Destefanis, M. / De Mori, F. / Ding, B. / Ding, X. X. / Ding, Y. / Dong, J. / Dong, L. Y. / Dong, M. Y. / Dong, X. / Du, M. C. / Du, S. X. / Duan, Z. H. / Egorov, P. / Fan, Y. L. / Fang, J. / Fang, S. S. / Fang, W. X. / Fang, Y. / Farinelli, R. / Fava, L. / Feldbauer, F. / Felici, G. / Feng, C. Q. / Feng, J. H. / Fischer, K / Fritsch, M. / Fritzsch, C. / Fu, C. D. / Fu, J. L. / Fu, Y. W. / Gao, H. / Gao, Y. N. / Gao, Yang / Garbolino, S. / Garzia, I. / Ge, P. T. / Ge, Z. W. / Geng, C. / Gersabeck, E. M. / Gilman, A / Goetzen, K. / Gong, L. / Gong, W. X. / Gradl, W. / Gramigna, S. / Greco, M. / Gu, M. H. / Gu, Y. T. / Guan, C. Y / Guan, Z. L. / Guo, A. Q. / Guo, L. B. / Guo, M. J. / Guo, R. P. / Guo, Y. P. / Guskov, A. / Han, T. T. / Han, W. Y. / Hao, X. Q. / Harris, F. A. / He, K. K. / He, K. L. / Heinsius, F. H. H. / Heinz, C. H. / Heng, Y. K. / Herold, C. / Holtmann, T. / Hong, P. C. / Hou, G. Y. / Hou, X. T. / Hou, Y. R. / Hou, Z. L. / Hu, H. M. / Hu, J. F. / Hu, T. / Hu, Y. / Huang, G. S. / Huang, K. X. / Huang, L. Q. / Huang, X. T. / Huang, Y. P. / Hussain, T. / Hüsken, N / Imoehl, W. / Irshad, M. / Jackson, J. / Jaeger, S. / Janchiv, S. / Jeong, J. H. / Ji, Q. / Ji, Q. P. / Ji, X. B. / Ji, X. L. / Ji, Y. Y. / Jia, X. Q. / Jia, Z. K. / Jiang, P. C. / Jiang, S. S. / Jiang, T. J. / Jiang, X. S. / Jiang, Y. / Jiao, J. B. / Jiao, Z. / Jin, S. / Jin, Y. / Jing, M. Q. / Johansson, T. / K., X. / Kabana, S. / Kalantar-Nayestanaki, N. / Kang, X. L. / Kang, X. S. / Kappert, R. / Kavatsyuk, M. / Ke, B. C. / Khoukaz, A. / Kiuchi, R. / Kliemt, R. / Kolcu, O. B. / Kopf, B. / Kuessner, M. K. / Kupsc, A. / Kühn, W. / Lane, J. J. / Larin, P. / Lavania, A. / Lavezzi, L. / Lei, T. T. / Lei, Z. H. / Leithoff, H. / Lellmann, M. / Lenz, T. / Li, C. / Li, C. H. / Li, Cheng / Li, D. M. / Li, F. / Li, G. / Li, H. / Li, H. B. / Li, H. J. / Li, H. N. / Li, Hui / Li, J. R. / Li, J. S. / Li, J. W. / Li, K. L. / Li, Ke / Li, L. J / Li, L. K. / Li, Lei / Li, M. H. / Li, P. R. / Li, Q. X. / Li, S. X. / Li, T. / Li, W. D. / Li, W. G. / Li, X. H. / Li, X. L. / Li, Xiaoyu / Li, Y. G. / Li, Z. J. / Li, Z. X. / Liang, C. / Liang, H. / Liang, Y. F. / Liang, Y. T. / Liao, G. R. / Liao, L. Z. / Libby, J. / Limphirat, A. / Lin, D. X. / Lin, T. / Liu, B. J. / Liu, B. X. / Liu, C. / Liu, C. X. / Liu, F. H. / Liu, Fang / Liu, Feng / Liu, G. M. / Liu, H. / Liu, H. B. / Liu, H. M. / Liu, Huanhuan / Liu, Huihui / Liu, J. B. / Liu, J. L. / Liu, J. Y. / Liu, K. / Liu, K. Y. / Liu, Ke / Liu, L. / Liu, L. C. / Liu, Lu / Liu, M. H. / Liu, P. L. / Liu, Q. / Liu, S. B. / Liu, T. / Liu, W. K. / Liu, W. M. / Liu, X. / Liu, Y. / Liu, Y. B. / Liu, Z. A. / Liu, Z. Q. / Lou, X. C. / Lu, F. X. / Lu, H. J. / Lu, J. G. / Lu, X. L. / Lu, Y. / Lu, Y. P. / Lu, Z. H. / Luo, C. L. / Luo, M. X. / Luo, T. / Luo, X. L. / Lyu, X. R. / Lyu, Y. F. / Ma, F. C. / Ma, H. L. / Ma, J. L. / Ma, L. L. / Ma, M. M. / Ma, Q. M. / Ma, R. Q. / Ma, R. T. / Ma, X. Y. / Ma, Y. / Ma, Y. M. / Maas, F. E. / Maggiora, M. / Malde, S. / Malik, Q. A. / Mangoni, A. / Mao, Y. J. / Mao, Z. P. / Marcello, S. / Meng, Z. X. / Messchendorp, J. G. / Mezzadri, G. / Miao, H. / Min, T. J. / Mitchell, R. E. / Mo, X. H. / Muchnoi, N. Yu. / Nefedov, Y. / Nerling, F. / Nikolaev, I. B. / Ning, Z. / Nisar, S. / Niu, Y. / Olsen, S. L. / Ouyang, Q. / Pacetti, S. / Pan, X. / Pan, Y. / Pathak, A. / Patteri, P. / Pei, Y. P. / Pelizaeus, M. / Peng, H. P. / Peters, K. / Ping, J. L. / Ping, R. G. / Plura, S. / Pogodin, S. / Prasad, V. / Qi, F. Z. / Qi, H. / Qi, H. R. / Qi, M. / Qi, T. Y. / Qian, S. / Qian, W. B. / Qiao, C. F. / Qin, J. J. / Qin, L. Q. / Qin, X. P. / Qin, X. S. / Qin, Z. H. / Qiu, J. F. / Qu, S. Q. / Redmer, C. F. / Ren, K. J. / Rivetti, A. / Rodin, V. / Rolo, M. / Rong, G. / Rosner, Ch. / Ruan, S. N. / Salone, N. / Sarantsev, A. / Schelhaas, Y. / Schoenning, K. / Scodeggio, M. / Shan, K. Y. / Shan, W. / Shan, X. Y. / Shangguan, J. F. / Shao, L. G. / Shao, M. / Shen, C. P. / Shen, H. F. / Shen, W. H. / Shen, X. Y. / Shi, B. A. / Shi, H. C. / Shi, J. L. / Shi, J. Y. / Shi, Q. Q. / Shi, R. S. / Shi, X. / Song, J. J. / Song, T. Z. / Song, W. M. / Song, Y. J. / Song, Y. X. / Sosio, S. / Spataro, S. / Stieler, F. / Su, Y. J. / Sun, G. B. / Sun, G. X. / Sun, H. / Sun, H. K. / Sun, J. F. / Sun, K. / Sun, L. / Sun, S. S. / Sun, T. / Sun, W. Y. / Sun, Y. / Sun, Y. J. / Sun, Y. Z. / Sun, Z. T. / Tan, Y. X. / Tang, C. J. / Tang, G. Y. / Tang, J. / Tang, Y. A. / Tao, L. Y / Tao, Q. T. / Tat, M. / Teng, J. X. / Thoren, V. / Tian, W. H. / Tian, Y. / Tian, Z. F. / Uman, I. / Wang, S. J. / Wang, B. / Wang, B. L. / Wang, Bo / Wang, C. W. / Wang, D. Y. / Wang, F. / Wang, H. J. / Wang, H. P. / Wang, J. P. / Wang, K. / Wang, L. L. / Wang, M. / Wang, Meng / Wang, S. / Wang, T. / Wang, T. J. / Wang, W. / Wang, W. P. / Wang, X. / Wang, X. F. / Wang, X. J. / Wang, X. L. / Wang, Y. / Wang, Y. D. / Wang, Y. F. / Wang, Y. H. / Wang, Y. N. / Wang, Y. Q. / Wang, Yaqian / Wang, Yi / Wang, Z. / Wang, Z. L. / Wang, Z. Y. / Wang, Ziyi / Wei, D. / Wei, D. H. / Weidner, F. / Wen, S. P. / Wenzel, C. W. / Wiedner, U. W. / Wilkinson, G. / Wolke, M. / Wollenberg, L. / Wu, C. / Wu, J. F. / Wu, L. H. / Wu, L. J. / Wu, X. / Wu, X. H. / Wu, Y. / Wu, Y. J. / Wu, Z. / Xia, L. / Xian, X. M. / Xiang, T. / Xiao, D. / Xiao, G. Y. / Xiao, H. / Xiao, S. Y. / Xiao, Y. L. / Xiao, Z. J. / Xie, C. / Xie, X. H. / Xie, Y. / Xie, Y. G. / Xie, Y. H. / Xie, Z. P. / Xing, T. Y. / Xu, C. F. / Xu, C. J. / Xu, G. F. / Xu, H. Y. / Xu, Q. J. / Xu, Q. N. / Xu, W. / Xu, W. L. / Xu, X. P. / Xu, Y. C. / Xu, Z. P. / Xu, Z. S. / Yan, F. / Yan, L. / Yan, W. B. / Yan, W. C. / Yan, X. Q. / Yang, H. J. / Yang, H. L. / Yang, H. X. / Yang, Tao / Yang, Y. / Yang, Y. F. / Yang, Y. X. / Yang, Yifan / Yang, Z. W. / Yao, Z. P. / Ye, M. / Ye, M. H. / Yin, J. H. / You, Z. Y. / Yu, B. X. / Yu, C. X. / Yu, G. / Yu, J. S. / Yu, T. / Yu, X. D. / Yuan, C. Z. / Yuan, L. / Yuan, S. C. / Yuan, X. Q. / Yuan, Y. / Yuan, Z. Y. / Yue, C. X. / Zafar, A. A. / Zeng, F. R. / Zeng, X. / Zeng, Y. / Zeng, Y. J. / Zhai, X. Y. / Zhai, Y. C. / Zhan, Y. H. / Zhang, A. Q. / Zhang, B. L. / Zhang, B. X. / Zhang, D. H. / Zhang, G. Y. / Zhang, H. / Zhang, H. H. / Zhang, H. Q. / Zhang, H. Y. / Zhang, J. J. / Zhang, J. L. / Zhang, J. Q. / Zhang, J. W. / Zhang, J. X. / Zhang, J. Y. / Zhang, J. Z. / Zhang, Jianyu / Zhang, Jiawei / Zhang, L. M. / Zhang, L. Q. / Zhang, Lei / Zhang, P. / Zhang, Q. Y. / Zhang, Shuihan / Zhang, Shulei / Zhang, X. D. / Zhang, X. M. / Zhang, X. Y. / Zhang, Y. / Zhang, Y. T. / Zhang, Y. H. / Zhang, Yan / Zhang, Yao / Zhang, Z. H. / Zhang, Z. L. / Zhang, Z. Y. / Zhao, G. / Zhao, J. / Zhao, J. Y. / Zhao, J. Z. / Zhao, Lei / Zhao, Ling / Zhao, M. G. / Zhao, S. J. / Zhao, Y. B. / Zhao, Y. X. / Zhao, Z. G. / Zhemchugov, A. / Zheng, B. / Zheng, J. P. / Zheng, W. J. / Zheng, Y. H. / Zhong, B. / Zhong, X. / Zhou, H. / Zhou, L. P. / Zhou, X. / Zhou, X. K. / Zhou, X. R. / Zhou, X. Y. / Zhou, Y. Z. / Zhu, J. / Zhu, K. / Zhu, K. J. / Zhu, L. / Zhu, L. X. / Zhu, S. H. / Zhu, S. Q. / Zhu, T. J. / Zhu, W. J. / Zhu, Y. C. / Zhu, Z. A. / Zou, J. H. / Zu, J.

    2023  

    Abstract: The $J/\psi \to \Xi^0 \bar{\Xi}^{0}$ process and subsequent decays are investigated using $(10087 ... of $\Xi^0$ and $\bar{\Xi}^0$ are measured with greatly improved precision over previous measurements to be ... alpha_{\Xi} = -0.3750 \pm 0.0034 \pm 0.0016$, $\bar{\alpha}_{\Xi} = 0.3790 \pm 0.0034 \pm 0.0021$, $\phi ...

    Abstract The $J/\psi \to \Xi^0 \bar{\Xi}^{0}$ process and subsequent decays are investigated using $(10087 \pm 44)\times 10^6$ $J/\psi$ events collected at the BESIII experiment. The decay parameters of $\Xi^0$ and $\bar{\Xi}^0$ are measured with greatly improved precision over previous measurements to be $\alpha_{\Xi} = -0.3750 \pm 0.0034 \pm 0.0016$, $\bar{\alpha}_{\Xi} = 0.3790 \pm 0.0034 \pm 0.0021$, $\phi_{\Xi} = 0.0051 \pm 0.0096 \pm 0.0018$~rad, $\bar{\phi}_{\Xi} = -0.0053 \pm 0.0097 \pm 0.0019$~rad, where the first and the second uncertainties are statistical and systematic, respectively. From these measurements, precise $CP$ symmetry tests in $\Xi^0$ decay are performed, and $A^{\Xi}_{CP} = (-5.4 \pm 6.5 \pm 3.1) \times 10^{-3}$ and $\Delta\phi^{\Xi}_{CP} = (-0.1 \pm 6.9 \pm 0.9) \times 10^{-3}$~rad are consistent with $CP$ conservation. The sequential decay also enables a separation of weak and strong phase differences, which are found for the first time to be $\xi_{P}-\xi_{S} = (0.0 \pm 1.7 \pm 0.2) \times 10^{-2}$~rad and $\delta_{P}-\delta_{S} = (-1.3 \pm 1.7 \pm 0.4)\times 10^{-2}$~rad, respectively. In addition, we measure the $\Lambda$ decay parameters and test $CP$ symmetry in $\Lambda$ decays.
    Keywords High Energy Physics - Experiment
    Subject code 612
    Publishing date 2023-05-16
    Publishing country us
    Document type Book ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    Full text online

    More links

    Kategorien

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  2. Article ; Online: Application of the Xi robotic platform for familial adenomatous polyposis with ultra-low rectal cancer: exploration of minimally invasive and refined therapies.

    Xiong, Huan / Wang, Jiaqi / Hu, Hanqing / Yuan, Ziming / Wang, Yuliuming / Qiao, Tianyu / Ma, Tianyi / Wang, Chunlin / Wang, Zitong / Tang, Qingchao

    Journal of robotic surgery

    2023  Volume 17, Issue 4, Page(s) 1843–1846

    Abstract: ... underwent total colectomy with abdominoperineal extended radical resection for rectal cancer using the Xi ...

    Abstract When a familial adenomatous polyposis (FAP) patient's rectal polyp undergoes malignant transformation, the surgeon needs to consider how to balance the quality of surgery with the patient's quality of life. Here, we present a case of robotic surgery in a patient with familial adenomatous polyposis and ultra-low rectal cancer. Fiberoptic colonoscopy found that hundreds of polyp-like bulges were diffusely distributed throughout the colon, and a malignant mass was found at the end of the rectum. The patient underwent total colectomy with abdominoperineal extended radical resection for rectal cancer using the Xi robotic platform. The patient recovered well in the postoperative period. The ileostomy was well used. And the patient was in good health and metastasis free at 9 months postoperatively. We identified total colectomy combined with extended radical rectal resection under the assistance of the da Vinci robot platform is of great benefit to the patient.
    MeSH term(s) Humans ; Robotics ; Robotic Surgical Procedures/methods ; Quality of Life ; Adenomatous Polyposis Coli/surgery ; Rectal Neoplasms/surgery ; Colectomy
    Language English
    Publishing date 2023-04-03
    Publishing country England
    Document type Case Reports ; Journal Article
    ZDB-ID 2268283-1
    ISSN 1863-2491 ; 1863-2483
    ISSN (online) 1863-2491
    ISSN 1863-2483
    DOI 10.1007/s11701-023-01587-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    Full text online

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  3. Article ; Online: Gene Variants in Two Families with Inherited Coagulation Factor XI Deficiency and Identification of Mutations.

    Jiang, Shuting / Chen, Yuan / Liu, Meina / Zeng, Manlin / Yang, Lihong / Jin, Yanhui / Jia, Kaiqi / Wang, Mingshan

    Acta haematologica

    2022  Volume 146, Issue 2, Page(s) 106–116

    Abstract: Introduction: Mutations in the F11 gene can cause factor XI (FXI) deficiency, leading to abnormal ...

    Abstract Introduction: Mutations in the F11 gene can cause factor XI (FXI) deficiency, leading to abnormal coagulation activity and injury-related bleeding tendency. Therefore, identifying F11 gene mutations and studying the molecular basis will help us understand the pathogenesis of FXI deficiency.
    Methods: Coagulation tests and gene sequencing analysis of all members were performed. FXI wild-type and mutant expression plasmids were constructed and transfected into HEK293FT cells. The FXI protein expression level was evaluated by ELISA and Western blot.
    Results: The FXI activity (FXI:C) and FXI antigen (FXI:Ag) of proband-1 were decreased to 2% and 5%, respectively. FXI:C and FXI:Ag of proband-2 were reduced to 15% and 32%, respectively. Four mutations were found in the two unrelated families, including c.536C>T (p.T179M), c.1556G>A (p.W519*), c.434A>G (p.H145R), and c.1325_1325delT (p.L442Cfs*8). In vitro studies in transiently transfected HEK293FT cells demonstrated that p.T179M, p.W519*, and p.L442Cfs*8 mutations significantly lowered the FXI levels in the culture media. The FXI levels in the culture media and cell lysates of p.H145R mutation were similar to the wild type.
    Conclusion: Our results confirm that the four mutations in the F11 gene are causative in the 2 FXI deficiency families. Moreover, the p.H145R mutation is a cross-reactive material (CRM)-positive phenotype. The other three mutations are CRM-negative phenotypes and lead to FXI protein secretion disorder.
    MeSH term(s) Humans ; Factor XI/genetics ; Factor XI Deficiency/genetics ; Mutation ; Exons ; Blood Coagulation
    Chemical Substances Factor XI (9013-55-2)
    Language English
    Publishing date 2022-12-21
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 80008-9
    ISSN 1421-9662 ; 0001-5792
    ISSN (online) 1421-9662
    ISSN 0001-5792
    DOI 10.1159/000528583
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Ud II Zs.145: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  4. Article ; Online: Exploration of the spatial relationship between Xi’an City and its mausoleums from the perspective of time evolution

    Jiaqi Liu / Lei Zhang / Jieyu Zhao / Yuan Liang / Qingxi Han / Sambirani Chirwa

    Frontiers in Ecology and Evolution, Vol

    2023  Volume 11

    Abstract: The ancient City of Xi’an has a history of more than 7,000 years of civilization, more than 3,100 ... development of urban areas, the number of imperial tombs in Xi’an has reached 72. These mausoleums are large in scale ... 2015–2022), and Pearson analysis to explore the temporal and spatial evolution law between Xi’an’s ...

    Abstract The ancient City of Xi’an has a history of more than 7,000 years of civilization, more than 3,100 years of City development, and 1,100 years of capital construction. With the gradual development of urban areas, the number of imperial tombs in Xi’an has reached 72. These mausoleums are large in scale and valuable, yet they are influenced by the rapid development of present urbanization, cities, and mausoleum spaces. The development contradictions between cities and mausoleum spaces progressively become prominent and need to be handled urgently. This article utilizes spacetime as the base scale, GIS spatio-temporal analysis, field research (including aerial photographs of unmanned aerial vehicle (UAV) in the 8 years, 2015–2022), and Pearson analysis to explore the temporal and spatial evolution law between Xi’an’s urban space and the 55 mausoleums dominated by emperors of various dynasties. It was concluded that the nuclear density area distance layout of Xi’an City and the mausoleum is closely related to time and space. Since ancient times, there has always been a relationship between the Spatio-temporal development of Xi’an City and its mausoleums, and the nuclear density area distance layout of the mausoleums is intimately connected to the status and nature of Xi’an City. Currently, mausoleums are part of site protection. However, because of the large space of the mausoleum, the contradiction between the protection and utilization of mausoleum sites and the development of urban space is revealed. This paper hopes to provide urban planners and site protectors with ideas and data support for the Spatio-temporal development of cities and mausoleums and realize the integration of the protection and renewal of mausoleum sites into the path of urban design and planning.
    Keywords urban spatial structure ; evolution of Spatio-temporal relations ; mausoleums and mausoleum-like large sites ; GIS ; Xi’an metropolitan area ; Evolution ; QH359-425 ; Ecology ; QH540-549.5
    Subject code 720
    Language English
    Publishing date 2023-05-01T00:00:00Z
    Publisher Frontiers Media S.A.
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    Full text online

    More links

    Kategorien

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  5. Book ; Online: First simultaneous measurement of $\Xi^0$ and $\bar{\Xi}^0$ asymmetry parameters in $\psi(3686)$ decay

    BESIII Collaboration / Ablikim, M. / Achasov, M. N. / Adlarson, P. / Aliberti, R. / Amoroso, A. / An, M. R. / An, Q. / Bai, Y. / Bakina, O. / Balossino, I. / Ban, Y. / Batozskaya, V. / Begzsuren, K. / Berger, N. / Bertani, M. / Bettoni, D. / Bianchi, F. / Bianco, E. /
    Bloms, J. / Bortone, A. / Boyko, I. / Briere, R. A. / Brueggemann, A. / Cai, H. / Cai, X. / Calcaterra, A. / Cao, G. F. / Cao, N. / Cetin, S. A. / Chang, J. F. / Chang, T. T. / Chang, W. L. / Che, G. R. / Chelkov, G. / Chen, C. / Chen, Chao / Chen, G. / Chen, H. S. / Chen, M. L. / Chen, S. J. / Chen, S. M. / Chen, T. / Chen, X. R. / Chen, X. T. / Chen, Y. B. / Chen, Y. Q. / Chen, Z. J. / Cheng, W. S. / Choi, S. K. / Chu, X. / Cibinetto, G. / Coen, S. C. / Cossio, F. / Cui, J. J. / Dai, H. L. / Dai, J. P. / Dbeyssi, A. / de Boer, R. E. / Dedovich, D. / Deng, Z. Y. / Denig, A. / Denysenko, I. / Destefanis, M. / De Mori, F. / Ding, B. / Ding, X. X. / Ding, Y. / Dong, J. / Dong, L. Y. / Dong, M. Y. / Dong, X. / Du, S. X. / Duan, Z. H. / Egorov, P. / Fan, Y. L. / Fang, J. / Fang, S. S. / Fang, W. X. / Fang, Y. / Farinelli, R. / Fava, L. / Feldbauer, F. / Felici, G. / Feng, C. Q. / Feng, J. H. / Fischer, K / Fritsch, M. / Fritzsch, C. / Fu, C. D. / Fu, Y. W. / Gao, H. / Gao, Y. N. / Gao, Yang / Garbolino, S. / Garzia, I. / Ge, P. T. / Ge, Z. W. / Geng, C. / Gersabeck, E. M. / Gilman, A / Goetzen, K. / Gong, L. / Gong, W. X. / Gradl, W. / Gramigna, S. / Greco, M. / Gu, M. H. / Gu, Y. T. / Guan, C. Y / Guan, Z. L. / Guo, A. Q. / Guo, L. B. / Guo, R. P. / Guo, Y. P. / Guskov, A. / H., X. T. / Han, W. Y. / Hao, X. Q. / Harris, F. A. / He, K. K. / He, K. L. / Heinsius, F. H. / Heinz, C. H. / Heng, Y. K. / Herold, C. / Holtmann, T. / Hong, P. C. / Hou, G. Y. / Hou, Y. R. / Hou, Z. L. / Hu, H. M. / Hu, J. F. / Hu, T. / Hu, Y. / Huang, G. S. / Huang, K. X. / Huang, L. Q. / Huang, X. T. / Huang, Y. P. / Hussain, T. / Hüsken, N / Imoehl, W. / Irshad, M. / Jackson, J. / Jaeger, S. / Janchiv, S. / Jeong, J. H. / Ji, Q. / Ji, Q. P. / Ji, X. B. / Ji, X. L. / Ji, Y. Y. / Jia, Z. K. / Jiang, P. C. / Jiang, S. S. / Jiang, T. J. / Jiang, X. S. / Jiang, Y. / Jiao, J. B. / Jiao, Z. / Jin, S. / Jin, Y. / Jing, M. Q. / Johansson, T. / K., X. / Kabana, S. / Kalantar-Nayestanaki, N. / Kang, X. L. / Kang, X. S. / Kappert, R. / Kavatsyuk, M. / Ke, B. C. / Khoukaz, A. / Kiuchi, R. / Kliemt, R. / Koch, L. / Kolcu, O. B. / Kopf, B. / Kuessner, M. / Kupsc, A. / Kühn, W. / Lane, J. J. / Lange, J. S. / Larin, P. / Lavania, A. / Lavezzi, L. / Lei, T. T. / Lei, Z. H. / Leithoff, H. / Lellmann, M. / Lenz, T. / Li, C. / Li, C. H. / Li, Cheng / Li, D. M. / Li, F. / Li, G. / Li, H. / Li, H. B. / Li, H. J. / Li, H. N. / Li, Hui / Li, J. R. / Li, J. S. / Li, J. W. / Li, Ke / Li, L. J / Li, L. K. / Li, Lei / Li, M. H. / Li, P. R. / Li, S. X. / Li, T. / Li, W. D. / Li, W. G. / Li, X. H. / Li, X. L. / Li, Xiaoyu / Li, Y. G. / Li, Z. J. / Li, Z. X. / Li, Z. Y. / Liang, C. / Liang, H. / Liang, Y. F. / Liang, Y. T. / Liao, G. R. / Liao, L. Z. / Libby, J. / Limphirat, A. / Lin, D. X. / Lin, T. / Liu, B. J. / Liu, B. X. / Liu, C. / Liu, C. X. / Liu, D. / Liu, F. H. / Liu, Fang / Liu, Feng / Liu, G. M. / Liu, H. / Liu, H. B. / Liu, H. M. / Liu, Huanhuan / Liu, Huihui / Liu, J. B. / Liu, J. L. / Liu, J. Y. / Liu, K. / Liu, K. Y. / Liu, Ke / Liu, L. / Liu, L. C. / Liu, Lu / Liu, M. H. / Liu, P. L. / Liu, Q. / Liu, S. B. / Liu, T. / Liu, W. K. / Liu, W. M. / Liu, X. / Liu, Y. / Liu, Y. B. / Liu, Z. A. / Liu, Z. Q. / Lou, X. C. / Lu, F. X. / Lu, H. J. / Lu, J. G. / Lu, X. L. / Lu, Y. / Lu, Y. P. / Lu, Z. H. / Luo, C. L. / Luo, M. X. / Luo, T. / Luo, X. L. / Lyu, X. R. / Lyu, Y. F. / Ma, F. C. / Ma, H. L. / Ma, J. L. / Ma, L. L. / Ma, M. M. / Ma, Q. M. / Ma, R. Q. / Ma, R. T. / Ma, X. Y. / Ma, Y. / Maas, F. E. / Maggiora, M. / Maldaner, S. / Malde, S. / Mangoni, A. / Mao, Y. J. / Mao, Z. P. / Marcello, S. / Meng, Z. X. / Messchendorp, J. G. / Mezzadri, G. / Miao, H. / Min, T. J. / Mitchell, R. E. / Mo, X. H. / Muchnoi, N. Yu. / Nefedov, Y. / Nerling, F. / Nikolaev, I. B. / Ning, Z. / Nisar, S. / Niu, Y. / Olsen, S. L. / Ouyang, Q. / Pacetti, S. / Pan, X. / Pan, Y. / Pathak, A. / Pei, Y. P. / Pelizaeus, M. / Peng, H. P. / Peters, K. / Ping, J. L. / Ping, R. G. / Plura, S. / Pogodin, S. / Prasad, V. / Qi, F. Z. / Qi, H. / Qi, H. R. / Qi, M. / Qi, T. Y. / Qian, S. / Qian, W. B. / Qiao, C. F. / Qin, J. J. / Qin, L. Q. / Qin, X. P. / Qin, X. S. / Qin, Z. H. / Qiu, J. F. / Qu, S. Q. / Redmer, C. F. / Ren, K. J. / Rivetti, A. / Rodin, V. / Rolo, M. / Rong, G. / Rosner, Ch. / Ruan, S. N. / Salone, N. / Sarantsev, A. / Schelhaas, Y. / Schoenning, K. / Scodeggio, M. / Shan, K. Y. / Shan, W. / Shan, X. Y. / Shangguan, J. F. / Shao, L. G. / Shao, M. / Shen, C. P. / Shen, H. F. / Shen, W. H. / Shen, X. Y. / Shi, B. A. / Shi, H. C. / Shi, J. L. / Shi, J. Y. / Shi, Q. Q. / Shi, R. S. / Shi, X. / Song, J. J. / Song, T. Z. / Song, W. M. / Song, Y. J. / Song, Y. X. / Sosio, S. / Spataro, S. / Stieler, F. / Su, Y. J. / Sun, G. B. / Sun, G. X. / Sun, H. / Sun, H. K. / Sun, J. F. / Sun, K. / Sun, L. / Sun, S. S. / Sun, T. / Sun, W. Y. / Sun, Y. / Sun, Y. J. / Sun, Y. Z. / Sun, Z. T. / Tan, Y. X. / Tang, C. J. / Tang, G. Y. / Tang, J. / Tang, Y. A. / Tao, L. Y / Tao, Q. T. / Tat, M. / Teng, J. X. / Thoren, V. / Tian, W. H. / Tian, Y. / Tian, Z. F. / Uman, I. / Wang, B. / Wang, B. L. / Wang, Bo / Wang, C. W. / Wang, D. Y. / Wang, F. / Wang, H. J. / Wang, H. P. / Wang, K. / Wang, L. L. / Wang, M. / Wang, Meng / Wang, S. / Wang, T. / Wang, T. J. / Wang, W. / Wang, W. H. / Wang, W. P. / Wang, X. / Wang, X. F. / Wang, X. J. / Wang, X. L. / Wang, Y. / Wang, Y. D. / Wang, Y. F. / Wang, Y. H. / Wang, Y. N. / Wang, Y. Q. / Wang, Yaqian / Wang, Yi / Wang, Z. / Wang, Z. L. / Wang, Z. Y. / Wang, Ziyi / Wei, D. / Wei, D. H. / Weidner, F. / Wen, S. P. / Wenzel, C. W. / Wiedner, U. / Wilkinson, G. / Wolke, M. / Wollenberg, L. / Wu, C. / Wu, J. F. / Wu, L. H. / Wu, L. J. / Wu, X. / Wu, X. H. / Wu, Y. / Wu, Y. J / Wu, Z. / Xia, L. / Xian, X. M. / Xiang, T. / Xiao, D. / Xiao, G. Y. / Xiao, H. / Xiao, S. Y. / Xiao, Y. L. / Xiao, Z. J. / Xie, C. / Xie, X. H. / Xie, Y. / Xie, Y. G. / Xie, Y. H. / Xie, Z. P. / Xing, T. Y. / Xu, C. F. / Xu, C. J. / Xu, G. F. / Xu, H. Y. / Xu, Q. J. / Xu, W. L. / Xu, X. P. / Xu, Y. C. / Xu, Z. P. / Yan, F. / Yan, L. / Yan, W. B. / Yan, W. C. / Yan, X. Q / Yang, H. J. / Yang, H. L. / Yang, H. X. / Yang, Tao / Yang, Y. / Yang, Y. F. / Yang, Y. X. / Yang, Yifan / Yang, Z. W. / Ye, M. / Ye, M. H. / Yin, J. H. / You, Z. Y. / Yu, B. X. / Yu, C. X. / Yu, G. / Yu, T. / Yu, X. D. / Yuan, C. Z. / Yuan, L. / Yuan, S. C. / Yuan, X. Q. / Yuan, Y. / Yuan, Z. Y. / Yue, C. X. / Zafar, A. A. / Zeng, F. R. / Zeng, X. / Zeng, Y. / Zeng, Y. J. / Zhai, X. Y. / Zhan, Y. H. / Zhang, A. Q. / Zhang, B. L. / Zhang, B. X. / Zhang, D. H. / Zhang, G. Y. / Zhang, H. / Zhang, H. H. / Zhang, H. Q. / Zhang, H. Y. / Zhang, J. J. / Zhang, J. L. / Zhang, J. Q. / Zhang, J. W. / Zhang, J. X. / Zhang, J. Y. / Zhang, J. Z. / Zhang, Jiawei / Zhang, L. M. / Zhang, L. Q. / Zhang, Lei / Zhang, P. / Zhang, Q. Y. / Zhang, Shuihan / Zhang, Shulei / Zhang, X. D. / Zhang, X. M. / Zhang, X. Y. / Zhang, Y. / Zhang, Y. T. / Zhang, Y. H. / Zhang, Yan / Zhang, Yao / Zhang, Z. H. / Zhang, Z. L. / Zhang, Z. Y. / Zhao, G. / Zhao, J. / Zhao, J. Y. / Zhao, J. Z. / Zhao, Lei / Zhao, Ling / Zhao, M. G. / Zhao, S. J. / Zhao, Y. B. / Zhao, Y. X. / Zhao, Z. G. / Zhemchugov, A. / Zheng, B. / Zheng, J. P. / Zheng, W. J. / Zheng, Y. H. / Zhong, B. / Zhong, X. / Zhou, H. / Zhou, L. P. / Zhou, X. / Zhou, X. K. / Zhou, X. R. / Zhou, X. Y. / Zhou, Y. Z. / Zhu, J. / Zhu, K. / Zhu, K. J. / Zhu, L. / Zhu, L. X. / Zhu, S. H. / Zhu, S. Q. / Zhu, T. J. / Zhu, W. J. / Zhu, Y. C. / Zhu, Z. A. / Zou, J. H. / Zu, J.

    2023  

    Abstract: The $\Xi^0$ asymmetry parameters are measured using entangled quantum $\Xi^0$-$\bar{\Xi}^0$ pairs ... The relative phase between the transition amplitudes of the $\Xi^0 \bar{\Xi}^0$ helicity states is measured ... alpha_{\bar{\Xi}^0}, \phi_{\Xi^0}, \phi_{\bar{\Xi}^0})$ and the angular distribution parameter $(\alpha ...

    Abstract The $\Xi^0$ asymmetry parameters are measured using entangled quantum $\Xi^0$-$\bar{\Xi}^0$ pairs from a sample of $(448.1 \pm 2.9) \times 10^6$ $\psi(3686)$ events collected with the BESIII detector at BEPCII. The relative phase between the transition amplitudes of the $\Xi^0 \bar{\Xi}^0$ helicity states is measured to be $\Delta \Phi = -0.050 \pm 0.150 \pm 0.020$~rad, which implies that there is no obvious polarization at the current level of statistics. The decay parameters of the $\Xi^0$ hyperon $(\alpha_{\Xi^0}, \alpha_{\bar{\Xi}^0}, \phi_{\Xi^0}, \phi_{\bar{\Xi}^0})$ and the angular distribution parameter $(\alpha_{\psi(3686)})$ and $\Delta \Phi$ are measured simultaneously for the first time. In addition, the $CP$ asymmetry observables are determined to be $A^{\Xi^0}_{CP} = (\alpha_{\Xi^0} + \alpha_{\bar{\Xi}^0})/(\alpha_{\Xi^0} - \alpha_{\bar{\Xi}^0})$ $= -0.007$ $\pm$ 0.082 $\pm$ 0.025 and $\Delta \phi^{\Xi^0}_{CP} = (\phi_{\Xi^0} + \phi_{\bar{\Xi}^0})/2$ $= -0.079$ $\pm$ 0.082 $\pm$ 0.010 rad, which are consistent with $CP$ conservation.

    Comment: 8 pages, 3 figures, 2 tables, consistent with paper published in Phys. Rev. D (Letter) 108, L011101(2023)
    Keywords High Energy Physics - Experiment
    Subject code 612
    Publishing date 2023-02-20
    Publishing country us
    Document type Book ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    Full text online

    More links

    Kategorien

    Inter-library loan at ZB MED

    Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

  6. Article: LINC00665/miRNAs axis-mediated collagen type XI alpha 1 correlates with immune infiltration and malignant phenotypes in lung adenocarcinoma.

    Zhu, Jun / Weng, Yuan / Wang, Fudong / Zhao, Jun

    Open medicine (Warsaw, Poland)

    2022  Volume 17, Issue 1, Page(s) 1259–1274

    Abstract: Collagen type XI alpha 1 (COL11A1) as an oncogene has been reported in several malignant tumors ...

    Abstract Collagen type XI alpha 1 (COL11A1) as an oncogene has been reported in several malignant tumors. Herein, we aimed to explore the function of COL11A1 and its upstream regulators in lung adenocarcinoma (LUAD). COL11A1 expression prognostic significance, gene ontology, Kyoto Encyclopedia of Genes and Genomes, and immune infiltration were explored in LUAD.
    Language English
    Publishing date 2022-07-13
    Publishing country Poland
    Document type Journal Article
    ZDB-ID 2829380-0
    ISSN 2391-5463
    ISSN 2391-5463
    DOI 10.1515/med-2022-0478
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  7. Article ; Online: Phenotype and genotype analysis of patients with severe factor XI deficiency in Shaanxi Province, China.

    Yuan, Li / Chen, Wei / Wang, Xiaoqin / Zhang, Heng

    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis

    2021  Volume 32, Issue 8, Page(s) 539–543

    Abstract: Congenital coagulation factor XI (FXI) deficiency is a rare bleeding disorder with a heterogeneous ...

    Abstract Congenital coagulation factor XI (FXI) deficiency is a rare bleeding disorder with a heterogeneous haemorrhagic phenotype and various hotspot gene mutations associated with race and geography. Studies on FXI deficiency in Shaanxi Province, China, are scarce. In this study, seven patients with severe FXI deficiency and several family members were analysed. The International Society on Thrombosis and Hemostasis-Bleeding Assessment Tool (ISTH-BAT) was applied to assess bleeding symptoms. FXI activity was determined using a one-stage method, and the FXI antigen was measured by enzyme-linked immunosorbent assay. Targeted capture next-generation sequencing and Sanger sequencing were applied to detect FXI gene mutations. The bleeding phenotype varied, although none of the participants had a history of spontaneous bleeding. One maternal received replacement therapy during the perinatal period, one female patient presented with menorrhagia, one male patient experienced severe postoperative bleeding and others were asymptomatic. Family members with heterozygous mutations were all asymptomatic. The FXI activity of all the patients ranged from less than 1 to 3.1 IU/dl, and a synchronous decrease in the FXI antigen was observed. Two missense mutations (p. Gly350Glu and p. Cys482Trp), one nonsense mutation (p. Gln384∗) and one novel frameshift mutation (p. Ser225Phefs∗16) were detected. The bleeding manifestations and severity of severe FXI deficiency varied and were not related to its activity. Three reported mutations and one novel frameshift mutation were identified, thus extending the mutation spectrum of FXI deficiency.
    MeSH term(s) Factor XI/genetics ; Factor XI Deficiency/genetics ; Female ; Heterozygote ; High-Throughput Nucleotide Sequencing ; Humans ; Male ; Phenotype
    Chemical Substances Factor XI (9013-55-2)
    Language English
    Publishing date 2021-11-12
    Publishing country England
    Document type Journal Article
    ZDB-ID 1033551-1
    ISSN 1473-5733 ; 0957-5235
    ISSN (online) 1473-5733
    ISSN 0957-5235
    DOI 10.1097/MBC.0000000000001061
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 2920: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (2.OG)
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  8. Article ; Online: Efficacy and safety of Jiu-Wei-Xi-Feng granules for treating tic disorders in children: study protocol for a randomized controlled equivalence trial.

    Guo, Sheng-Xuan / Li, Rui-Ben / Hu, Si-Yuan / Cai, Qiu-Han / Zhong, Cheng-Liang / Hao, Rui-Min

    Trials

    2022  Volume 23, Issue 1, Page(s) 898

    Abstract: ... in childhood. Jiu-Wei-Xi-Feng granules has been marketed in China for treating children with TD. As Long Gu (Os ... between Jiu-Wei-Xi-Feng granules (Os Draconis replaced by Concha Ostreae) (JWXFD) and Jiu-Wei-Xi-Feng ...

    Abstract Background: Tic disorders (TD) is a neuropsychiatric disease with twitch as the main manifestation in childhood. Jiu-Wei-Xi-Feng granules has been marketed in China for treating children with TD. As Long Gu (Os Draconis) in the composition of this Chinese patent medicine is a rare and expensive medicinal material protected by the Chinese government, therefore, we consider replacing it with Mu Li (Concha Ostreae) that has the same effect and is cheaper. This study is designed to evaluate the clinical equivalence between Jiu-Wei-Xi-Feng granules (Os Draconis replaced by Concha Ostreae) (JWXFD) and Jiu-Wei-Xi-Feng granules (original formula) (JWXFO) in children with TD (consumption of renal yin and liver wind stirring up internally syndrome).
    Methods/design: This is a multicenter, randomized, double-blind, equivalence trial comparing the efficacy and safety of JWXFD and JWXFO in treating Children with tic disorders (consumption of renal yin and liver wind stirring up internally syndrome). A total of 288 patients will be recruited and randomly assigned to two groups in a 1:1 ratio. The treatment course is 6 weeks, with a 2 weeks follow-up. The primary outcome is the mean change value from baseline to 6th week by the Yale Global Tic Severity Scale total tic score (YGTSS-TTS). Secondary outcomes include total effective rate of tic, Yale Global Tic Severity Scale (YGTSS) scores and its factor scores (the degree of motor tics, phonic tics and social function damage), Clinical Global Impression-Severity scale, and TCM syndrome efficacy.
    Discussion: The design of this study refers to a large number of similar research design points, and asked for opinions of peer experts, and finally reached a consensus. This trial will provide high-quality evidence on the clinical equivalence between JWXFD and JWXFO and provide a basis for the marketing of JWXFD.
    Trial registration: ChiCTR2000032312 Registered on 25 April 2020, http://www.chictr.org.cn/showproj.aspx?proj=52630.
    MeSH term(s) Child ; Humans ; Tics/therapy ; Treatment Outcome ; Tic Disorders/diagnosis ; Tic Disorders/drug therapy ; Double-Blind Method ; Syndrome ; Nonprescription Drugs ; Randomized Controlled Trials as Topic ; Multicenter Studies as Topic
    Chemical Substances Nonprescription Drugs
    Language English
    Publishing date 2022-10-22
    Publishing country England
    Document type Clinical Trial Protocol ; Journal Article
    ZDB-ID 2040523-6
    ISSN 1745-6215 ; 1468-6694 ; 1745-6215
    ISSN (online) 1745-6215
    ISSN 1468-6694 ; 1745-6215
    DOI 10.1186/s13063-022-06802-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  9. Article ; Online: Associations of coagulation factor X and XI with incident acute coronary syndrome and stroke: A nested case-control study.

    Chen, Huiting / Shen, Miaoyan / Niu, Rundong / Mu, Xuanwen / Jiang, Qin / Peng, Rong / Yuan, Yu / Wang, Hao / Wang, Qiuhong / Yang, Handong / Guo, Huan / He, Meian / Zhang, Xiaomin / Wu, Tangchun

    Journal of thrombosis and haemostasis : JTH

    2021  Volume 19, Issue 11, Page(s) 2781–2790

    Abstract: ... unclear whether coagulation factors X (FX) and XI (FXI) levels are associated with cardiovascular diseases ...

    Abstract Background: Coagulation cascade contributes to thrombotic and hemorrhagic diseases, but it remains unclear whether coagulation factors X (FX) and XI (FXI) levels are associated with cardiovascular diseases.
    Objective: To evaluate prospective associations of FX and FXI levels with incident acute coronary syndrome (ACS), stroke, and their subtypes (acute myocardial infarction, unstable angina, ischemic stroke, and hemorrhagic stroke).
    Methods: We performed a nested case-control study (n = 1846) within the Dongfeng-Tongji cohort from 2013 to 2016 matched on age (within 1 year), sex, and sampling date (within 1 month) by incidence density sampling, and measured plasma FX and FXI levels by enzyme-linked immunosorbent assay. FX and FXI levels were categorized into three groups (low, <25th; middle, 25th to <75th; and high ≥75th percentiles) according to distributions, and conditional logistic regression models were used to estimate odds ratios (ORs) and 95% confidence intervals (CIs).
    Results: After adjustment for traditional cardiovascular risk factors, compared with middle groups, the OR (95% CI) in high levels of FX and FXI were 1.11 (0.79-1.56) and 0.96 (0.68-1.36) for incident ACS, and 1.01 (0.63-1.62) and 1.72 (1.14-2.60) for incident stroke, respectively. As for subtypes of ACS and stroke, only high FXI levels were significantly associated with incident ischemic stroke (OR 1.66, 95% CI 1.05-2.65). Moreover, all associations remained steady after additional adjustment for platelet and leukocyte.
    Conclusion: FXI levels were associated with a greater risk of incident ischemic stroke but not hemorrhagic stroke or ACS. FX levels were not associated with incident ACS or stroke.
    MeSH term(s) Acute Coronary Syndrome/diagnosis ; Acute Coronary Syndrome/epidemiology ; Case-Control Studies ; Factor X ; Factor XI ; Humans ; Stroke/diagnosis ; Stroke/epidemiology
    Chemical Substances Factor X (9001-29-0) ; Factor XI (9013-55-2)
    Language English
    Publishing date 2021-08-31
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2112661-6
    ISSN 1538-7836 ; 1538-7933
    ISSN (online) 1538-7836
    ISSN 1538-7933
    DOI 10.1111/jth.15486
    Database MEDical Literature Analysis and Retrieval System OnLINE

    Full text online

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 5805: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (2.OG)
    ab Jg. 2022: Lesesaal (EG)
    Zs.MO 295: Show issues

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  10. Article ; Online: Risk prediction in infective endocarditis by modified MELD-XI score.

    He, Peng-Cheng / Wei, Xue-Biao / Luo, Si-Ni / Chen, Xiao-Lan / Ke, Zu-Hui / Yu, Dan-Qing / Chen, Ji-Yan / Liu, Yuan-Hui / Tan, Ning

    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

    2018  Volume 37, Issue 7, Page(s) 1243–1250

    Abstract: ... MELD-XI) score to predict adverse outcomes in infective endocarditis (IE) patients remains uncertain ... This study was performed to explore the prognostic value of the MELD-XI score and modified MELD-XI score ... groups: MELD-XI ≤ 10 (n = 588) and MELD-XI > 10 (n = 270). Multivariate analysis was performed ...

    Abstract The suitability of the model for end-stage liver disease excluding international normalized ratio (MELD-XI) score to predict adverse outcomes in infective endocarditis (IE) patients remains uncertain. This study was performed to explore the prognostic value of the MELD-XI score and modified MELD-XI score for patients with IE. A total of 858 patients with IE were consecutively enrolled and classified into two groups: MELD-XI ≤ 10 (n = 588) and MELD-XI > 10 (n = 270). Multivariate analysis was performed to determine risk factors independent of MELD-XI score. Higher MELD-XI score was associated with higher in-hospital mortality (15.6 vs. 4.8%, p < 0.001) and major adverse clinical events (33.3 vs. 18.4%, p < 0.001). MELD-XI score was an independent predictor of in-hospital death (odds ratio [OR] = 1.06, 95% CI, 1.02-1.10, p = 0.005). Based on a multivariate analysis, NYHA class III or IV (3 points), C-reactive protein > 9.5 mg/L (4 points), and non-surgical treatment (6 points) were added to MELD-XI score. Modified MELD-XI score produced higher predictive power than previous (AUC 0.823 vs. 0.701, p < 0.001). The cumulative incidence of long-term mortality (median 29 months) was significantly higher in patients with modified MELD-XI score > 13 than those without (log-rank = 25.30, p < 0.001). Modified MELD-XI score was independently associated with long-term mortality (hazard ratio = 1.08, 95% CI, 1.04-1.12, p < 0.001). MELD-XI score could be used as a risk assessment tool in IE. Furthermore, modified MELD-XI score remained simple and more effective in predicting poor prognosis.
    MeSH term(s) Adult ; C-Reactive Protein/analysis ; End Stage Liver Disease/diagnosis ; Endocarditis, Bacterial/diagnosis ; Endocarditis, Bacterial/mortality ; Female ; Humans ; Male ; Middle Aged ; Prognosis ; Risk Factors ; Severity of Illness Index
    Chemical Substances C-Reactive Protein (9007-41-4)
    Language English
    Publishing date 2018-03-29
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 603155-9
    ISSN 1435-4373 ; 0934-9723 ; 0722-2211
    ISSN (online) 1435-4373
    ISSN 0934-9723 ; 0722-2211
    DOI 10.1007/s10096-018-3240-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    Full text online

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 1732: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (1.OG)
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

To top